German Other Utilities Stock News

Why Vonovia’s new tender offer matters for stockholders Vonovia (XTRA:VNA) has launched a cash tender offer for six euro bond series maturing between 2027 and 2028, alongside plans to issue new notes. The company aims to reshape its near term debt profile. This refinancing step sits alongside an updated voting rights figure of 848,435,117 following a conditional capital increase. Together, these details provide fresh context on both Vonovia’s funding mix and equity base as you assess the...

In recent weeks, European markets have shown resilience, with the pan-European STOXX Europe 600 Index rising nearly 2% as lower oil prices and easing inflation concerns bolstered investor sentiment. In this context of cautious optimism, growth companies with high insider ownership can be particularly appealing as they often signal strong confidence from those closest to the business, potentially aligning well with investors seeking stability and commitment in uncertain times.

Fresh commentary on the growing fumed silica market, particularly for hydrophobic grades, has put Evonik Industries (XTRA:EVK) in focus as investors consider the potential implications of wider industrial uses for the stock. See our latest analysis for Evonik Industries. Against the backdrop of growing interest in hydrophobic fumed silica, Evonik Industries’ share price has a year to date return of 20.81%, while the 1 year total shareholder return is slightly lower at a decline of 1.19%,...

In late June 2026, Siemens AG entered a partnership with IFS AB to link Siemens’ Digital Twin and automation capabilities with IFS’s asset and service data, aiming to create AI-enabled, closed-loop industrial workflows, while also initiating a €6.00 billion share buyback through 2031 and investing €300.00 million to expand German production and add 700 jobs by 2030. Together, these moves highlight Siemens’ push to fuse industrial AI with real-world asset data while simultaneously using its...

Bayer (XTRA:BAYN) has reorganized its U.S. glyphosate operations into Ruveon LLC, a dedicated unit that will oversee pricing, market approach, production, and logistics as part of the Crop Science Five-Year Framework. See our latest analysis for Bayer. The Ruveon reorganization arrives alongside a sharp swing in sentiment toward Bayer, with a 30 day share price return of 56.48% and a 1 year total shareholder return of 105.42%, suggesting momentum has recently strengthened. If this kind of...

Siemens Energy stock has delivered a very large 3 year return while the valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to some upside and the broader checks and market multiples suggesting the shares are not an obvious bargain. A very large 3 year gain of around 10x puts recent Siemens Energy returns front and center for anyone thinking about what the stock is worth today. Strong order momentum for gas turbines and recent contract wins in...

BASF stock has delivered a 30.2% gain over the past three years, yet current valuation checks suggest the shares now sit closer to “about right” than clearly cheap or expensive. Over the last three years, BASF has returned 30.2%, which puts current buyers in a different position from those who entered before this move. Recent product launches such as SkinNexus Collag3n in personal care and the Melooop based automotive interior concept can support sentiment around future cash flows. However,...

Germany’s regulator BaFin has opened a formal audit into Zalando (XTRA:ZAL) over possible omissions in the 2025 accounts related to the About You acquisition, drawing fresh attention to the stock’s recent share price move. See our latest analysis for Zalando. The BaFin audit lands at a time when Zalando’s 1 month share price return of 13.02% and 3 month share price return of 26.90% point to building short term momentum, even though the 1 year total shareholder return declined 5.76% and the 5...

Evotec (XTRA:EVT) is back in focus after Just – Evotec Biologics rolled out J.TRAIN, a turnkey platform that lets biopharmaceutical companies install its continuous biologics manufacturing technology directly inside their own facilities. See our latest analysis for Evotec. While J.TRAIN is drawing attention to Evotec's biologics capabilities, the stock price tells a mixed story, with a 1-day share price return of 1.94% and a 90-day share price return of 13.15% set against a 1-year total...

Redcare Pharmacy index changes catch investor attention Redcare Pharmacy (XTRA:RDC) has shifted within Germany's equity indices, exiting the MDAX Performance Index on 19 June 2026 and joining the SDAX Total Return Index on 22 June 2026, drawing fresh interest to the stock. See our latest analysis for Redcare Pharmacy. The index reshuffle comes after a sharp rebound in Redcare Pharmacy's share price, with a 30 day share price return of 50.95% and a 90 day share price return of 87.13%. However,...

As Google faces a €4.1b antitrust fine in Europe, attention is shifting to European technology stocks that operate in areas like search, browsers, mobile software and app marketplaces without the same global dominance. For investors, this kind of regulatory pressure can sometimes change the balance of power, opening space for regional competitors or altering how large platforms work with partners and users. This article looks at 3 European Technology Competitors that are directly exposed to...

As the European market navigates a mixed landscape of easing inflation expectations and fluctuating stock performances, investors are increasingly focused on companies with strong insider ownership, which can signal confidence in long-term growth potential. In this context, identifying growth stocks backed by insiders can be a strategic approach for those looking to align with entities that demonstrate resilience and commitment amidst economic uncertainties.

As global markets navigate a landscape marked by mixed performances across major indices, small-cap stocks have emerged as resilient players, with the Russell 2000 Index advancing significantly. Amidst rising inflation and evolving economic indicators, investors are increasingly focused on identifying stocks that offer growth potential and stability in the face of market volatility. In this environment, a good stock is often characterized by strong fundamentals, unique market positioning, and...

The European Medicines Agency committee recently recommended revoking the EU marketing authorisation for TAVNEOS®, affecting Fresenius Medical Care's treatment portfolio for kidney patients across the region. This regulatory setback raises questions about how Fresenius Medical Care will adapt its European therapy offering while continuing to invest in digital kidney care initiatives. We’ll now examine how the potential loss of TAVNEOS® in the EU reshapes Fresenius Medical Care’s longer-term...

Siltronic (XTRA:WAF) has moved into the Germany MDAX Index after exiting the SDAX, a reshuffle that can prompt index tracking funds to adjust positions and potentially influence short term trading volumes. See our latest analysis for Siltronic. Beyond the index reshuffle, Siltronic’s 1 day share price return of 7.3% and 90 day share price return of 64.2% sit alongside a 1 year total shareholder return of 107%. This points to strong recent momentum despite a 30 day share price return that is...

Potential Krona Public Real Estate AB (publ) ( FRA:927 ) shareholders may wish to note that the Director, Tomas...

The market seemed underwhelmed by last week's earnings announcement from ADM Hamburg Aktiengesellschaft ( FRA:OEL...

Bechtle Schuldschein placement draws strong investor interest Bechtle (XTRA:BC8) has completed its second Schuldschein loan, raising €450 million after strong demand led to an oversubscribed order book and an early close. This outcome highlights broad investor appetite for the company’s debt. See our latest analysis for Bechtle. The Schuldschein success comes as Bechtle’s share price has shown short term support, with a 1 day share price return of 3.10% and 7 day share price return of 4.65%...

Bayerische Motoren Werke (XTRA:BMW) has completed a $1.7b investment in its US operations, supporting expansion at Spartanburg and a new Woodruff battery plant to enable local production of the fully electric BMW iX5. See our latest analysis for Bayerische Motoren Werke. The latest €58.2 share price comes after a sharp 30 day share price decline of 21.05% and a year to date drop of 39.58%, while the 1 year total shareholder return is down 22.17%. This suggests recent momentum has been weak...

2G Energy (XTRA:2GB) has opened FY 2025 with first half revenue of €170.3 million and net income of €3.5 million, while the trailing 12 month figures show revenue of €416.3 million and net income of €24.5 million, setting a clear earnings benchmark against the current share price of €71.70. The company has seen revenue move from €131.2 million in the first half of 2024 to €246.0 million in the second half of 2024, with EPS shifting from €0.15 to €1.17 over the same period. Trailing data now...

Why Siemens Energy Stock Is Back In Focus After Oman and AI Summit News Siemens Energy (XTRA:ENR) has attracted fresh attention after announcing agreements to supply power generation technology and long-term services for two major projects in Oman, shortly before presenting at the ISG AI Impact Summit 2026. The Misfah and Duqm combined cycle gas turbine plants are expected to lift Oman’s electricity capacity and supply power to more than two million people, with Siemens Energy providing six F...

Smartbroker Holding (XTRA:SB1) has just posted its FY 2025 first half figures, with revenue of €32.5 million and a basic EPS loss of €0.31. This places a clear focus on how the business is balancing growth with profitability. The company has seen revenue move from €25.7 million in the first half of 2024 to €26.9 million in the second half of 2024 and now €32.5 million in the first half of 2025. EPS has shifted from a loss of €0.12 in early 2024 to a small profit of €0.04 in late 2024 before...

HMS Bergbau (XTRA:HMU) has released its FY 2025 figures with first half revenue of €643.0 million and basic EPS of €1.26, set against trailing twelve month revenue of about €1.3 billion and basic EPS of €2.97. Over recent periods the company has seen revenue move from €731.4 million in the first half of 2024 to €632.3 million in the second half of 2024 and then €643.0 million in the first half of 2025. Basic EPS has ranged from €1.22 to €1.69 over 2024 before landing at €1.26 in the latest...

RWE (XTRA:RWE) is back in focus after its Meton Energy joint venture with Public Power Corporation commissioned three photovoltaic clusters in northern Greece, adding 930 MWp of solar capacity to its European renewables portfolio. See our latest analysis for RWE. At a share price of €56.62, RWE has recorded a 1-month share price return of 3.78% and a year to date share price return of 20.70%. The 1-year total shareholder return of 60.16% points to strong recent momentum, despite a 3-month...